... Journal of Medicinal Chemistry. ... In 2005, a pharmaceutical company patented a new generation of 5-HT 6 receptor antagonists based on the 3-benzenesulfonyl-8-piperazine-1-ylquinoline scaffold.(18) Within this scaffold, N-methyl derivative 1 presented high binding affinity ...